Risk factors for CVT
| Local risk factors (8%-12%) . | Mechanical causes (2%-5%) . | CNS disorders (2%) . | Systemic risk factors . |
|---|---|---|---|
| Infections involving the ears, sinuses, mouth, face, neck, CNS | Trauma, lumbar puncture, jugular vein catheterization, neurosurgical interventions | Arteriovenous malformation, dural fistulae, CNS malignancies | Pregnancy/puerperium (10%-17% women), hormonal treatment (50%-53% women), thrombophilia (approx. 33%), myeloproliferative neoplasms (3%-4%), COVID-19 infection, COVID-19 vaccines (AstraZeneca, J&J) |
| Local risk factors (8%-12%) . | Mechanical causes (2%-5%) . | CNS disorders (2%) . | Systemic risk factors . |
|---|---|---|---|
| Infections involving the ears, sinuses, mouth, face, neck, CNS | Trauma, lumbar puncture, jugular vein catheterization, neurosurgical interventions | Arteriovenous malformation, dural fistulae, CNS malignancies | Pregnancy/puerperium (10%-17% women), hormonal treatment (50%-53% women), thrombophilia (approx. 33%), myeloproliferative neoplasms (3%-4%), COVID-19 infection, COVID-19 vaccines (AstraZeneca, J&J) |
Adapted from Riva et al.4
CNS, central nervous system.